Search - tctmd.com

Displaying 541 - 557 of 557

Sort: Relevancy | Date

News Daily News

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Jason Kahn

February 11, 2013

Presentation TCT 2013

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger, Bryce Einhorn, Vladimir Jelnin, Leandro Maranan, Gila Perk, itzhak kronzon, Howard Cohen, Carlos Ruiz

January 31, 2013

Presentation TCT 2012

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger

October 23, 2012

News Conference News ESC 2012

Registries Show Strides for Transcatheter Valve Treatments in Europe

Caitlin E. Cox

August 27, 2012

News Daily News

Una Encuesta Revela que, en EE.UU., la Formación Intervencionista Estructural está en su ‘Más Tierna Infancia’

Jason Kahn

July 31, 2012

News Daily News

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

Jason Kahn

July 31, 2012

Presentation

SCAI Structural Heart Disease Early Career Task Force Survey Results

Presenter: Konstantinos Marmagkiolis

July 30, 2012

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

CME

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

CME

TAVR in Expanded Patient Populations: Exploring the Next Frontier

CME

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

CME

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

CME

Low-Risk Patients: The Changing Face of TAVR

Improving TAVR Outcomes Duirng COVID-19: The Role Virtual Proctoring & CME

CME

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

CME

Defining Cost-Effectiveness and Quality of Life for TAVR

CME

Advertisement

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

TCT-81. Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Registries Show Strides for Transcatheter Valve Treatments in Europe

Una Encuesta Revela que, en EE.UU., la Formación Intervencionista Estructural está en su ‘Más Tierna Infancia’

Survey Reflects US Structural Intervention Training in Its ‘Infancy’

SCAI Structural Heart Disease Early Career Task Force Survey Results

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Transcatheter Aortic Valve Replacements for Bicuspid Aortic Valves

TAVR in Expanded Patient Populations: Exploring the Next Frontier

TAVR and Imaging Modalities: Impact on Clinical Practice and Decision Making

Optimization of Clinical Pathways for Treating Low Risk Patients with severe AS

Low-Risk Patients: The Changing Face of TAVR

Improving TAVR Outcomes During COVID-19: The Role Virtual Proctoring & CME

Defining Cost-Effectiveness and Quality of Life for TAVR

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content